Showing 2680 results for "amyotrophic lateral sclerosis (ALS)"

RESCUE-ALS Phase 2 Trial Completes Enrollment Ahead of Schedule

Patient enrollment is now complete for the Phase 2 clinical trial of Clene Nanomedicine‘s CNM-Au8 as a potentially disease-modifying therapy for amyotrophic lateral sclerosis (ALS). The trial, named RESCUE-ALS (NCT04098406) will test the safety, efficacy, pharmacokinetics, and pharmacodynamics —…

CONSENT FOR SURVEY PARTICIPATION (no-contact)

1. Why is this survey being conducted? The purpose of this survey is to gather information from individuals with amyotrophic lateral sclerosis (ALS) so that Bionews and its partners can bring better understanding, advocacy, and provide our readers more relevant editorial content to the larger ALS community. 2. What will…

CONSENT FOR SURVEY PARTICIPATION

CONSENT FOR SURVEY PARTICIPATION Why is this survey being conducted? The purpose of this survey is to gather information from individuals with amyotrophic lateral sclerosis (ALS) so that Bionews Services and its partners can bring better understanding, advocacy, and provide our readers more relevant editorial content to the larger ALS…